Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Romaine C. Nichols, MD
UF Health Proton Therapy Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Florida Proton Therapy Institute
Jacksonville, Florida, United States
Active, not recruiting - Northwestern Medicine Chicago Proton Center
Warrenville, Illinois, United States
Nasiruddin Mohammed, MDRecruiting - Mclaren Proton Therapy Center
Flint, Michigan, United States
Brian Yeh, MDRecruiting - Inova Schar Cancer Institute
Fairfax, Virginia, United States
Michael Eblan, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2016
- Primary completion
- 31 Oct 2039
- Completion
- 31 Oct 2040
- Last update posted
- 9 Sept 2025
- Registered enrollment
- 60
- Registry id
- NCT02598349
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.